Keisuke Goto - Search Results

Year	Number of Results
2002	1
2003	2
2004	1
2007	1
2010	1
2011	3
2012	5
2013	3
2014	6
2015	11
2016	17
2017	19
2018	9
2019	12
2020	17
2021	34
2022	42
2023	31
2024	17

1

Muscle-Invasive Bladder Cancer With Hydronephrosis Exhibits a High Frequency of Mutations in Fibroblast Growth Factor Receptor 3 Gene.

Kobatake K, Ikeda K, Kohada Y, Tasaka R, Takemoto K, Fukushima T, Miyamoto S, Sekino Y, Kitano H, Goto K, Hieda K, Goriki A, Hayashi T, Hinata N. Kobatake K, et al. Among authors: goto k. Anticancer Res. 2024 May;44(5):1947-1954. doi: 10.21873/anticanres.16997. Anticancer Res. 2024. PMID: 38677755

2

Loss of p16 Immunoexpression and Deletions of CDKN2A in the Progression of Extramammary Paget Disease: An Immunohistochemical and Genetic Study of 24 Invasive/Metastatic Cases.

Hiraki T, Oishi T, Yoshikawa S, Honma K, Ohe S, Isei T, Kukita Y, Takai T, Shimada K, Takei Y, Goto K. Hiraki T, et al. Among authors: goto k. Am J Dermatopathol. 2024 Apr 23. doi: 10.1097/DAD.0000000000002726. Online ahead of print. Am J Dermatopathol. 2024. PMID: 38648029

3

Risk classification system using the detailed positive surgical margin status for predicting biochemical recurrence after robot-assisted radical prostatectomy.

Hatayama T, Goto K, Fujiyama K, Goriki A, Kaneko M, Mita K. Hatayama T, et al. Among authors: goto k. Asia Pac J Clin Oncol. 2024 Mar 21. doi: 10.1111/ajco.14053. Online ahead of print. Asia Pac J Clin Oncol. 2024. PMID: 38512888

4

Nesprin1 deficiency is associated with poor prognosis of renal cell carcinoma and resistance to sunitinib treatment.

Fukushima T, Kobatake K, Miura K, Takemoto K, Yamanaka R, Tasaka R, Kohada Y, Miyamoto S, Sekino Y, Kitano H, Goto K, Ikeda K, Goriki A, Hieda K, Kaminuma O, Hinata N. Fukushima T, et al. Among authors: goto k. Oncology. 2024 Mar 5. doi: 10.1159/000536539. Online ahead of print. Oncology. 2024. PMID: 38442705

5

Association of Nutritional Indices With Adverse Effects and Time-to-Treatment-Failure in Triple Therapy for Lung Cancer.

Hashino Y, Matushita T, Hatsuyama T, Wakamoto A, Goto K, Hoshi T, Iwayama K, Ohtaki K, Toda T, Sato H. Hashino Y, et al. Among authors: goto k. In Vivo. 2024 Mar-Apr;38(2):864-872. doi: 10.21873/invivo.13512. In Vivo. 2024. PMID: 38418111 Free PMC article.

6

Centrality angle is a novel nephrometry score to predict tumor complexity and perioperative outcomes for partial nephrectomy.

Miyamoto S, Goto K, Tasaka R, Kohada Y, Fukushima T, Takemoto K, Babasaki T, Kobatake K, Sekino Y, Kitano H, Ikeda K, Hieda K, Hayashi T, Hinata N. Miyamoto S, et al. Among authors: goto k. Sci Rep. 2024 Feb 27;14(1):4780. doi: 10.1038/s41598-024-55448-0. Sci Rep. 2024. PMID: 38413713 Free PMC article.

7

Recurrent GATA3 P409Afs*99 Frameshift Extension Mutations in Sweat-gland Carcinoma With Neuroendocrine Differentiation.

Goto K, Kiniwa Y, Kukita Y, Ohe S, Hiraki T, Hishima T, Takai T, Honma K. Goto K, et al. Am J Surg Pathol. 2024 May 1;48(5):528-537. doi: 10.1097/PAS.0000000000002195. Epub 2024 Feb 14. Am J Surg Pathol. 2024. PMID: 38353459

8

SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors.

Macagno N, Kervarrec T, Thanguturi S, Sohier P, Pissaloux D, Mescam L, Jullie ML, Frouin E, Osio A, Faisant M, Le Loarer F, Cribier B, Calonje E, Luna EVE, Massi D, Goto K, Nishida H, Paindavoine S, Houlier A, Tantot J, Benzerdjeb N, Tirode F, De la Fouchardière A, Battistella M. Macagno N, et al. Among authors: goto k. Mod Pathol. 2024 Mar;37(3):100430. doi: 10.1016/j.modpat.2024.100430. Epub 2024 Jan 23. Mod Pathol. 2024. PMID: 38266920

9

Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.

Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Nishiyama N, Kimura T, Yamashita S, Kitamura H, Miyake H; Japanese Urological Oncology Group. Matsushita Y, et al. Among authors: goto k. Int J Urol. 2024 Jan 19. doi: 10.1111/iju.15396. Online ahead of print. Int J Urol. 2024. PMID: 38240169

10

PIK3CA mutation status in apocrine carcinoma arising in apocrine gland hyperplasia/apocrine nevus: A study of four cases.

Goto K, Kiniwa Y, Hishima T, Honma K, Matsushita S, Aoki M, Nishihara K, Hiraki T. Goto K, et al. J Cutan Pathol. 2024 Jan 18. doi: 10.1111/cup.14588. Online ahead of print. J Cutan Pathol. 2024. PMID: 38238254 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

197 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year